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AbSTRACT
In thalassaemic patients, the impact of the disease especially on quality of life (QOL) of the caregivers in Malaysia has 
not been established. This study was conducted to assess the health-related quality of life (HRQOL) of thalassaemia 
patients and their caregivers in order to explore factors affecting their QOL. A cross-sectional study was conducted on 
75 thalassaemic children and adolescents aged between 7 and 18 years old and their caregivers. The PedsQLTM 4.0 
generic core scales questionnaire was administered to both thalassaemic children and their caregivers while the health 
questionnaire EQ 5D was given to caregivers only. The subjects were recruited from Hospital Kuala Lumpur (HKL) 
and Universiti Kebangsaan Malaysia Medical Centre (UKMMC). The results revealed that the mean of psychosocial 
HRQOL score in patients (63.91±14.65) was significantly lower than parent proxy reports (67.14±10.48) (p=0.008). The 
school functioning score (50.59±15.31) was the lowest of the psychosocial measure, followed by emotional functioning 
(59.92±16.83) and social functioning (78.01±13.92) score. The patients’ pre-transfusion haemoglobin concentration 
was significantly associated with their QOL (p=0.02). Having more children, higher numbers of thalassaemic children 
and lower educational level of caregivers were associated with poorer QOL. In conclusion, caregivers underestimated 
the QOL of their thalassaemic children. The school functioning domain was affected the most domain. There is a need to 
improve the QOL of thalassaemic children and their caregivers.
Keywords: Caregivers; education; paediatrics; quality of life; thalassemia 
AbSTRAK
Bagi pesakit talasemia, kesan penyakit terutamanya ke atas kualiti hidup penjaga mereka di Malaysia masih belum 
difahami. Penyelidikan ini telah dijalankan untuk menilai kualiti hidup berkaitan kesihatan (HRQOL) dalam kalangan 
pesakit talasemia serta penjaga mereka bagi mengetahui faktor-faktor yang mempengaruhi kualiti hidup mereka. Kajian 
keratan lintang telah dijalankan ke atas 75 pesakit talasemia kanak-kanak dan remaja berumur antara 7 dan 18 tahun 
serta penjaga mereka. Borang soal-selidik PedsQLTM 4.0 generic core scales telah diberikan kepada pesakit dan penjaga 
sementara borang soal-selidik kesihatan EQ 5D diberikan kepada penjaga sahaja. Subjek direkrut dari Hospital Kuala 
Lumpur (HKL) dan Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM). Keputusan menunjukkan min skor 
HRQOL psikososial dalam kalangan pesakit (63.91±14.65) adalah lebih rendah secara signifikan berbanding laporan 
proksi penjaga (67.14±10.48) (p=0.008). Skor fungsian sekolah (50.59±15.31) adalah paling rendah antara pengukuran 
psikososial, diikuti skor fungsian emosi (59.92±16.83) dan fungsian sosial (78.01±13.92). Kepekatan hemoglobin pra-
transfusi berkait secara signifikan dengan kualiti hidup mereka (p=0.02). Anak yang lebih ramai, jumlah anak yang 
menghidap talasemia yang lebih ramai serta tahap pendidikan penjaga yang rendah dikaitkan dengan kualiti hidup 
yang kurang memuaskan. Kesimpulannya, penjaga didapati memandang rendah isu kualiti hidup anak-anak talasemia 
mereka. Domain fungsian sekolah didapati paling bermasalah. Oleh itu, terdapat keperluan untuk meningkatkan kualiti 
hidup pesakit talasemia kanak-kanak dan remaja serta penjaga mereka.
Kata kunci: Kualiti hidup; pediatrik; pendidikan; penjaga; talasemia
inTRoduCTion
Thalassaemia indicates a heterogeneous group of genetic 
disorders of haemoglobin synthesis characterized by 
a disturbance of globin chains’ production, leading to 
anaemia, ineffective erythropoiesis and destruction of 
erythroblast in the bone marrow and erythrocytes in the 
peripheral blood (Higgs et al. 2001). Alpha thalassaemia 
is commonly found in southern Asia and southern China. 
However, beta thalassaemia is more common in the 
Mediterranean countries, the Middle east, the indian 
subcontinent, South east Asia, Russia and northern 
China (Leung et al. 2008; olivieri & brittenham 1997; 
Weatherall 1981). The ethnic population of Malaysia 
comprises Malays (54.3%), Chinese (25%), indians 
(7.5%) and other indigenous group (13.2%) (department 
of Statistic Malaysia 2010). in Malaysia, thalassaemia 
occurs mainly amongst the Malays and Chinese population. 
Approximately 4.5% of Malaysians are heterozygous 
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carriers of beta thalassaemia and these couples are at risk 
of having a child with beta thalassaemia major; affected 
annual births is estimated to be 2.1/1,000 (george 2001). 
The Malaysian Ministry of Health estimated that about 
150 to 350 babies are born each year with thalassaemia 
(Tam 2005). george (2001) estimated that there were 5,600 
blood transfusion dependent beta thalassaemia patients in 
Malaysia.
 Thalassaemia affects patients’ health-related quality 
of life (HRQoL). Children with thalassaemia major have to 
undergo blood transfusion at least once a month, depending 
on the severity of the disease. iron chelation therapy such 
as desferrioxamine is required to remove excessive iron in 
the blood, which resulted from regular blood transfusion 
(Anionwu & Atkin 2001; Saeed 2004). in addition, the 
disease itself may have profound impact on the patients’ 
physical appearance, such as bone deformities and short 
stature which leads to poor self-image (ismail et al. 2006; 
Telfer et al. 2005).
 The paediatric health-related quality of life (HRQoL) 
measurement is recognized as an important health outcome 
in the trial, review and evaluation of health services (Matza 
et al. 2004; Varni et al. 1999). Although efforts to measure 
quality of life (QoL) of children are complex, more and 
more generic measures of disease-specific tools have been 
reported (eiser & Morse 2001). HRQoL of the physical, 
psychological and social domains of health are influenced 
by experiences, beliefs, expectations and perceptions 
(Matza et al. 2004). HRQoL is a multidimensional concept 
that represents the patient’s overall perception regarding 
the impact of the illness and its treatment (Shumaker & 
berzon 1995). it can be used to describe the impacts of the 
disease or illness in individuals in addition to evaluating 
the impact of individual treatments or programs of services 
to the population. furthermore, assessment of HRQoL can 
also predict the future status of people with a certain illness 
(Spilker 1996).
 As there are limited studies focusing on thalassaemic 
children and their caregivers QoL, the aim of this study 
was to assess the health-related quality of life (HRQoL) of 
thalassaemia children, adolescents and their caregivers in 
order to explore factors affecting their quality of life to 
improve overall management.
MATeRiALS And MeTHodS
A cross-sectional study was conducted among children and 
adolescents, aged 7 and 18 years old with beta thalassaemia 
major, Hbe beta thalassaemia and thalassaemia intermedia 
who received regular blood transfusion treatment (1 to 
3 times monthly) at Hospital Kuala Lumpur (HKL) and 
universiti Kebangsaan Malaysia Medical Centre (uKMMC) 
and their caregivers, from August 2009 till january 2010. 
The study was approved by the national institute of Health 
(niH) (nMRR-09-289-3405) and ethics Committee, Medical 
Research Secretariat, uKMMC (ff-290-2008). in addition 
to age, further inclusion criteria for patients were ability 
to read, write and understand Malay, english or Mandarin. 
The caregivers were defined as either the father or mother 
of the patient. Written informed consent was obtained from 
all participants.
 The quality of life assessment of patients was 
performed using the paediatric quality of life inventory™ 
(PedsQL™) 4.0 generic core scale which was developed 
to measure health-related quality of life (HRQoL) in healthy 
children and adolescent and those with acute and chronic 
health problems. A user agreement was signed with the 
MAPi Research institute, Lyon, france, prior to the use of 
the questionnaire. The PedsQL 4.0 generic core scale was 
designed for developmentally appropriate which includes 
parallel child self reports and parent proxy reports (age 
ranges 5-7, 8-12 and 13-18 years) were administered 
following the PedsQLTM administration guidelinesSM. 
PedsQL items required subjects to report problems 
regarding physical, emotional, social and schooling 
function that have arisen for the past one month. The 23 
items’ responses were measured on a five-point rating scale 
ranging from 0 (never a problem) to 4 (almost always a 
problem), yielding a total score and two summary scores 
(i.e. physical health and psychosocial health). each 
scale had a score ranging from 0 to 100, the higher score 
indicating higher QoL. The PedsQL has demonstrated 
good internal consistency and validity in large samples 
of children with acute and chronic health conditions, as 
well as in healthy children and adolescents. furthermore, 
its reliability has been tested by the previous use of the 
PedsQL 4.0 generic core scale (Malay version) in Malaysia 
(ismail et al. 2006). 
 The quality of life assessment of patients’ caregivers 
was performed using eQ 5d descriptive system which 
consists of five dimensions as follows: mobility, self care, 
usual activity, pain/discomfort and worry/depression. 
each dimension had three levels: no problems, some 
problems and severe problems. The respondents were 
asked to indicate his/her health state by ticking in the box 
against the most appropriate statement in each of the five 
dimensions. This decision resulted in a 1-digit number 
expressing the level selected for that dimension. The digits 
for five dimensions were combined in a 5-digit number 
describing the respondent’s health state. Validation was 
done and reliability for use in Malaysia has been tested 
(Mahadeva et al. 2008; van Agt et al. 1994).
 Socio demographic data and clinical parameters 
were obtained from the patients’ medical records. These 
included demographics of the patients (gender, age, ethnic 
and educational level) and clinical information (type of 
thalassaemia, onset of thalassaemia, haemoglobin (Hb) level, 
type of chelation therapy, age at first transfusion  frequency 
of blood transfusion and iron chelation treatment). 
 Statistical analysis was carried out using statistical 
package for social sciences (SPSS) version 16. general 
characteristics of the patients were presented in terms of 
percentage, mean and standard deviation. differences in 
the health-related quality of life (HRQoL) score between 
thalassaemia patients’ self report and parent’s proxy report 
were tested using the Mann-Whitney test. for HRQoL, both 
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total HRQoL score and summary scores were presented in 
terms of mean and standard deviation. Mann-Whitney 
u, Kruskal-Wallis and the chi-square test were used 
to examine the relationship between HRQoL and each 
demographic/clinical parameter. A p value of ≤0.05 was 
considered statistically significant.
ReSuLTS And diSCuSSion
A total of 75 thalassaemic patients from Hospital Kuala 
Lumpur (HKL) and uKM Medical Centre (uKMMC) and 
64 caregivers were approached. The majority of patients 
were Malays (69%), followed by Chinese (25%) and other 
ethnic groups (5%) (Table 1). The mean age of patients 
was 11.9±3.3 years for boys and 12.3±2.8 for girls. The 
majority of patients (44%) are from families with household 
incomes of RM1500-RM3000 (uSd484.97-uSd969.93). The 
percentages of patients diagnosed with beta-thalassaemia 
major, Hbe-beta thalassaemia and thalassaemia intermedia 
were 72%, 23% and 5%, respectively. The mean duration 
of diagnosis is 9.93 ± 3.40 years with mean duration of 
chelation therapy is 8.69 ± 4.19 years. The mean pre-
transfusion haemoglobin concentration measured three 
months prior to the HRQoL assessment was approximately 
8.88±1.69 g/dL. The majority of patients received blood 
transfusion once per month (88%) and chelation treatment 
3 to 6 times per week (56%). Sixty-three percent of the 
caregivers were mothers. The mean age of caregivers was 
45.3±6.3 years for men and 42.9±6.6 years for women. 
The majority of caregivers hailed from high educational 
background (upper secondary and above) (73%), were from 
the urban area (63%) and were working (58%). The majority 
of caregivers also had 1 to 3 children (67%) and most of 
them had only one child with thalassaemia (69%).
TAbLe 1. demographic and clinical characteristics of thalassaemia patients
Mean ± Sd n (%)
gender (n=75) 
  female 
  Male
36 (48)
39 (52)
Age (years)(n=75)
 5 – 7
  8 – 12
  13 – 18
6 (8)
34 (45)
35 (47)
educational level (n=75)
 no formal education
 Primary school 
  Lower secondary school
  Higher secondary school and above
1 (1)
41 (55)
27 (36)
6 (8)
family income (n=68)
 < RM1500 (uSd 484.97)
  RM1500-RM3000 (uSd484.97-969.93)
  > RM3000 (uSd969.93)
RM3206.3 ± 2852.7
uSd1036.6 ± 922.3
15 (20)
30 (40)
23 (30)
Hb (n=57)
  < 7 g/dL 
  7-9 g/dL 
  > 9 g/dL
8.88 ± 1.69
6 (11)
24 (42)
27 (47)
Type of chelation (n=73)
  none
  desferrioxamine
  deferasirox
  deferiprone
8 (11)
51 (70)
13 (18)
1 (1)
frequency of transfusion (n=75)
  4-6 monthy
  2-3 monthly
  Monthly 
1 (1)
8 (11)
66 (88)
frequency of chelation therapy (n=72)
  none
  daily
  3-6 times per week 
  <3 times per week 
8 (11)
21 (29)
40 (56)
3 (4)  
*RM is an acronym for Malaysian Ringgit
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 in this study, we found that the mean total summary 
scores among thalassaemia children (65.35±10.57) were 
lower than parents’ proxy reports (67.20±11.36); p value 
was however 0.136 (Table 2), while physical functioning 
score for patients’ self report (69.67±12.51) was higher than 
the parents’ proxy report (67.25±14.28), but with p value 
0.337. The mean psychosocial health score was significantly 
lower (p<0.01) for patients’ self report (63.91±14.65) than 
for parents’ proxy report (67.14±10.48). Psychosocial 
subscale revealed that school functioning scored the lowest 
for both patients’ self report (50.59±15.31) and parents’ 
proxy report (52.21±18.85) (p=0.605). These findings are 
consistent with previous studies that showed parents may 
overestimate or underestimate patients’ QoL while some 
studies showed high correlation between both reports. 
(baraz et al. 2010; eiser & Morse 2001; Matza et al. 2004; 
Reinfjell et al. 2006; Russell et al. 2006; Simeoni et al. 
2001; Varni et al. 2006). The mean total summary score of 
patients’ self report in this study was lower compared with 
findings by Ismail et al. (2006) which was 68.91±12.12. 
on the other hand, mean physical functioning score and 
mean social functioning score of patient’s self report in 
this study was higher compared with ismail et al. (2006) 
which were 69.15±16.45) and 74.29±18.77, respectively. 
ismail et al. (2006) had conducted a study to evaluate the 
HRQoL status of 64 thalassaemia patients in Kuala Lumpur, 
Malaysia using the PedsQL 4.0. 
 The mean psychosocial health score of patients’ self 
report (63.91±14.65) in our study was lower compared 
with ismail et al. (2006) which was 67.58±12.77. This 
low psychosocial health score supports previous studies 
on patients with thalassaemia, whereby more psychosocial 
support should be given to thalassaemia patients not only 
from the government but also from non-government 
organisations such as the Thalassaemia Association of 
Malaysia (Aydinok et al. 2005; goldbeck et al. 2000). 
 in our study, the score for emotional functioning 
subscale was lower compared with previous studies. Mean 
emotional function score was reported to be 68.14±17.22 
by ismail et al. (2006) while a study by upton et al. (2005) 
on children had reported that mean emotional function 
score for children with athme, cancer and diabetes was 
70.66±20.06, 73.56±18.39 and 78.85±18.28, respectively. 
According to Pakbaz et al. (2005) emotional functioning is 
one of the weaker domains among thalassaemia children 
as they experience anxiety, depression and concerns 
over their health status. As with previous studies, the 
school functioning subscale scored the lowest (ismail 
et al. 2006). This low school functioning score is due to 
patients requiring regular blood transfusion in hospital; 
as a result patients are intermittently absent from school 
which ultimately gave a negative impact on their HRQoL 
(Anionwu & Atkin 2001; Saeed 2004).
 Pre-transfusion haemoglobin (Hb) level, frequency 
of transfusion and frequency of chelation therapy were 
found to be significant predictors of HRQoL scores 
(Tables 3 & 4). The study revealed that patients whose 
Hb level was higher than 9 g/dL had a significantly 
higher (p=0.02) total summary score (68.41±7.69) than 
those with Hb levels of 7-9 g/dL (66.00±8.98) or less 
than 7 g/dL (46.30±17.53) in patients’ self report. This 
result is supported by dahlui et al. (2009) in his study on 
thalassaemia patients and also consistent with the findings 
from several studies conducted on other diseases that 
also address the association between Hb concentration 
and quality of life (Afsar et al. 2009; finkelstein et al. 
2008; Santos 2008; Thein et al. 2009). Lower Hb level is 
associated with a number of symptoms, such as fatigue, 
general weakness and decreased mental alertness, which 
may lead to impaired HRQoL of the patients (Shumaker 
& berzon 1995). Pre-transfusion Hb level should be 
monitored routinely to maintain an optimal level of 9-10.5 
g/dL (Shaligram et al. 2007).
  As reported in previous studies, we found that there 
was a significant relationship between frequency of 
blood transfusion and HRQoL (p=0.034), with patients 
receiving more frequent blood transfusion having lower 
psychosocial health score when compared with patients 
receiving less frequent blood transfusion (Anionwu & 
Atkin 2001; Saeed 2004). The patients typically have 
to undergo for blood transfusions at least once a month 
depending on the severity of the illness. This means 
attendance for an entire day at the hospital which leads to 
school absenteeism and might impaired HRQoL indirectly. 
our study also showed that frequency of iron chelation 
treatment was significantly related to HRQoL impairment 
TAbLe 2. Comparison of PedsQLTM 4.0 score between patients’ self report and parents’ proxy report
Scale Patients’ self report 
(n=75)
Mean ± Sd
Parents’ proxy report 
(n=75)
Mean ± Sd
p value
Total summary score 
Physical functioning 
Psychosocial health 
  emotional functioning
  Social functioning
  School functioning
65.35 ± 10.57
69.67 ± 12.51
63.91 ± 14.65
59.92 ± 16.83
78.01 ± 13.92
50.59 ± 15.31
67.20 ± 11.36
67.25 ± 14.28
67.14 ± 10.48
74.06 ± 5.36
76.03 ± 3.73
52.21 ± 18.85
0.136
0.337
0.008
0.000
0.027
0.605
Mann Whitney Test
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TAbLe 3. Patients’ self report HRQoL score based on clinical characteristics
Mean ± Sd Total summary Physical functioning Psychosocial health
Hb 
 < 7 g/dL (n=6)
 7-9 g/dL (n=24)
  > 9g/dL (n=27)
p valuea
46.30 ± 17.53
66.00 ± 8.98
68.41 ± 7.69
0.020
51.04 ± 14.34
69.92 ± 9.43
73.73 ± 13.29
0.008
44.72 ± 19.02
64.69 ± 11.07
66.64 ± 8.03
0.021
 frequency of transfusion 
  4-6 monthly (n=1)
  2-3 monthly (n=8)
  Monthly (n=66)
p valuea
90.47
72.29 ± 9.36
64.02 ± 10.24
0.072
71.88
66.02 ± 7.36
69.91 ± 13.38
0.733
96.67
74.38 ± 11.82
62.06 ± 10.48
0.034
frequency of chelation therapy 
  none (n=8)
  daily (n=21)
  3-6 times a week (n=40)
  <3 times a week (n=3)
p valuea
71.41 ± 10.56
66.05 ± 11.10
65.52 ± 8.47
48.91 ± 10.13
0.036
69.14 ± 5.89
70.94 ± 12.79
70.09 ± 13.03
57.29 ± 6.51
0.140
72.17 ± 13.22
64.70 ± 12.34
63.71 ± 8.88
46.11 ± 11.34
0.031
Kruskal-Wallis Test
TAbLe 4. Parents’ proxy report HRQoL score based on clinical characteristics
Mean ± Sd
Total summary Physical functioning Psychosocial health
Hb
 < 7 g/dL (n=6)
 7-9 g/dL (n=24)
 > 9g/dL (n=27)
p valuea
72.19 ± 10.70
62.38 ± 11.73
68.77 ± 9.48
0.159
71.88 ± 13.83
61.47 ± 14.07
69.59 ± 13.17
0.351
72.50 ± 10.21
63.29 ± 11.15
67.96 ± 7.84
0.176
 frequency of transfusion 
  4-6 monthly (n=1)
  2-3 monthly (n=8)
  Monthly (n=66)
p valuea
82.50
67.82 ± 10.72
66.66 ± 11.14
0.485
75.00
67.10 ± 14.61
66.97 ± 13.70
0.540
90.00
68.54 ± 10.63
66.34 ± 10.31
0.261
frequency of chelation therapy 
  none (n=8)
  daily (n=21)
  3-6 times a week (n=40)
  >3 times a week (n=3)
p valuea
72.10 ± 8.04
70.17 ± 13.65
64.71 ± 9.33
56.39 ± 13.83
0.036
74.61 ± 10.75
70.51 ± 17.87
63.69 ± 11.00
58.33 ± 18.31
0.030
69.58 ± 7.33
69.84 ± 11.41
65.73 ± 10.01
54.44 ± 10.18
0.053
Kruskal-Wallis Test
which was similar to other reported studies (Abetz et al. 
2006; Shaligram et al. 2006). Patients receiving more 
frequent chelation treatment (everyday) had higher total 
summary score (p=0.036), higher physical functioning 
score (p=0.140) and higher psychosocial health score 
(p=0.031) as compared with patients receiving less 
frequent chelation treatment. A more frequent chelation 
therapy may lead to increment in iron losses which 
indirectly influence their quality of life.
 Concordant with the findings from previous studies, 
gender, type of thalassaemia (i.e. beta thalassaemia major, 
Hbe-beta thalassaemia and thalassaemia intermedia) and 
type of chelation were not related to HRQoL (dahlui et al. 
2009). We also found that ethnicity and family income 
were not significantly related with HRQoL. Similar findings 
were reported by ismail et al. (2006) in a study among 
thalassaemia patients in Malaysia. Age, educational level 
and patients’ bMi were also not significantly related with 
HRQoL in this study. 
 figure 1 shows the proportion and frequency of eQ 
5d according to the various dimension. The majority of 
caregivers reported no concerns in the various dimension of 
eQ 5d. A total of 84.4%, 100%, 67.2%, 65.6% and 56.2% 
caregivers reported no issues in dimension mobility, self 
care, usual activity, pain/discomfort and worry/depression, 
respectively. 
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 Caregivers’ with more than one thalassaemia child 
reported more problems with usual activity (p=0.02), pain/
discomfort (p=0.25) and anxiety/depression dimensions 
(p=0.030) (Table 5). it was found that caregivers with 
lower educational level reported more problems in anxiety/
depression dimension when compared with caregivers with 
higher educational level (p=0.002). our results showed 
that caregivers with more than one affected child are 
faced with more problems. This may be due to increased 
physical and mental stress resulting in impaired QoL 
among caregivers. Our findings also found that caregivers 
with lower educational levels experience more problems. 
Lower educational level may be associated with poorer 
understanding of the nature of the disease which in turn 
may affect the psychosocial aspects of this group of 
parents.
 A limitation of this study was the absence of a control 
group of healthy children. Nevertheless, the findings of 
this study highlight the significant negative impact of 
thalassaemia on patients’ HRQoL in terms of physical 
functioning and psychosocial functioning, especially in 
the school functioning subscale. The study also found the 
significant negative impact of thalassaemia on caregivers’ 
HRQoL in terms of various dimensions. Considering that the 
TAbLe 5. Relationship of various dimensions of eQ 5d with number of children 
with thalassaemia and caregivers’ educational level
dimension no of thalassaemia children p value
1 >1
usual activity
 no problem
 Some problem
34 (79.1)
10 (47.6)
9 (20.9)
11 (52.4)
0.020
Pain/discomfort
  no problem
  Some problem
33 (78.6)
11 (50.0)
9 (21.4)
11 (50.0)
0.025
Anxiety/depression
  no problem 
  Some problem
29 (80.6)
15 (53.6)
7 (19.4)
13 (46.4)
0.030
Caregivers’ educational level
Low
(Lower secondary and 
below)
High
(upper secondary and 
above)
Anxiety/depression
  no problem
 Some problem
4 (11.1)
13 (46.4)
32 (88.9)
15 (53.6)
0.002
 
Chi-square Test
*Values are presented as number (percentage)
figuRe 1. Percentage of eQ 5d dimension of caregivers
dimension of eQ 5d
Pe
rce
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)
no problem
Some problem
extreme problem
  379
prevalence of thalassaemia in Malaysia, our study suggests 
that improvement of the welfare and social support system 
should be further improved. Health campaigns can be 
held to help patients and caregivers cope better with 
thalassaemia. Patients, school officials, family and hospital 
officials should always maintain contact and surveillance 
of their patients’ well-being. 
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